The privilege of conducting research with recombinant or synthetic nucleic acid molecules and/or infectious agents, human cell lines and other human materials used in research, toxins of biological origin, or Select Agents and Toxins at Tufts University and/or Tufts Medical Center depends on the institutions’ compliance with federal, state, and local regulations governing this research. To this end, the Institutional Biosafety Committees have been charged with enforcing a mandatory biosafety training policy to ensure that all personnel listed on an active IBC registration have been provided the training necessary to understand the risk associated with the use of the material and understand how to conduct research safely and with appropriate knowledge of the regulations that govern its use. All of the pertinent regulations are listed below. Please review each for additional information. Non-compliance with this policy will be followed up by the IBC regulatory office.
The Institutional Biosafety Committees of Tufts Cummings School of Veterinary Medicine and Tufts University/Tufts Medical Center recognize that much relevant training occurs within each laboratory and that many individuals have experience that qualifies them in certain aspects of the use of biohazardous agents. However, we believe attendance by all those involved in IBC-regulated research is essential. Principal Investigators must keep in mind that it is their responsibility to guarantee the appropriate training of their students, associates, and staff and to make sure that their research programs are in compliance with all pertinent regulations and institutional policies. The Environmental Health and Safety (EHS) staff members provide initial and refresher courses to help all those listed on an IBC registration understand how to comply and how to conduct their research while minimizing risk. It will be necessary for all individuals who have completed this training requirement to be documented as such by the IBCs.
All individuals listed on active IBC registrations at Tufts Cummings School of Veterinary Medicine, Tufts University, and Tufts Medical Center will be required to attend.
From the NIH Guidelines:
From the “Biosafety in Microbiological and Biomedical Laboratories” (BMBL) (NIH) 5th ed.:
From Boston Public Health Commission (BPHC) “Regulating Recombinant DNA:”
From Town of Grafton “Article 27: Biomedical Research and Production By-Law:”